RPG Life Sciences Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in
RPG Life Sciences Ltd Q2FY24; 30% rise in Profits
Categories
Health Care
Glenmark Pharmaceuticals Limited Q2 FY24 Earnings Conference Call Insights
Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q2 FY24 Earnings Concall Financial Results Revenue increased 6.3% YoY to INR35,879 million. India formulation
Wockhardt Ltd Q2FY24; 11% rise in Revenue
Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams and ointments).
Marksans Pharma Limited Q2 FY24 Earnings Conference Call Insights
Key highlights from Marksans Pharma Limited (MARKSANS) Q2 FY24 Earnings Concall Financial Performance Revenues grew 17% year-on-year to INR531 crores in Q2
Procter & Gamble Health Ltd Q2FY24; 3% rise in Profits
P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing of pharmaceuticals
Aurobindo Pharma Limited Q2 FY24 Earnings Conference Call Insights
Key highlights from Aurobindo Pharma Limited (AUROPHARMA) Q2 FY24 Earnings Concall Revenue Growth Revenue grew 25.8% year-on-year to INR7,219 crores, driven by
Suven Pharmaceuticals Ltd Q2FY24; 11% rise in Profits
Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. Financial
Sanofi India Ltd Q2FY24; 16% rise in Profits
Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Financial Results: Sanofi India Ltd reported Revenues for Q2FY24
Supriya Lifescience Ltd Q2FY24; 41% rise in Profits
Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs
Vijaya Diagnostic Centre Ltd Q2FY24; 48% rise in Profits
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
Sequent Scientific Ltd Q2FY24; 2% rise in Revenue
Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging
Divi’s Laboratories Ltd Q2 FY24 Earnings Conference Call Insights
Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q2 FY24 Earnings Concall Business Overview Anticipating growth opportunities in contrast media, sartans, soon-to-expire patented
TTK Healthcare Ltd Q2FY24; 60% rise in Profits
TTK Healthcare Ltd is engaged in the business of Pharmaceuticals, Consumer Products, Medical Devices, Protective Devices and Foods. It is a part
Dr Lal PathLabs Ltd Q2 FY24 Earnings Conference Call Insights
Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q2 FY24 Earnings Concall Financial Performance Revenue for Q2 FY24 was INR601 crores, up
Religare Enterprises Ltd Q2FY24; 36% rise in Revenue
Religare Enterprise Ltd, incorporated in 1984, is a diversified financial services company with presence all over India, operating through its subsidiaries. The
Sun Pharmaceuticals Industries Ltd Q2FY24; 6% rise in Profits
Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations
Thyrocare Technologies Ltd Q2FY24; 43% rise in Profits
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to
Strides Pharma Science Ltd Q2FY24; 11% rise in Revenue
Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products. The company's pharmaceutical products are sold in
Cipla Limited Q2 FY24 Earnings Conference Call Insights
Key highlights from Cipla Limited (CIPLA) Q2 FY24 Earnings Concall Financial Performance Highest ever quarterly revenue of INR6,678 crores, up 15% YoY.
Torrent Pharmaceuticals Ltd Q2 FY24 Earnings Conference Call Insights
Key highlights from Torrent Pharmaceuticals Ltd (TORNTPHARM) Q2 FY24 Earnings Concall Revenue Growth Across Key Markets India business revenue grew 18% year-on-year;
Torrent Pharmaceuticals Ltd Q2FY24; 24% rise in Profits
Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.